全文获取类型
收费全文 | 979篇 |
免费 | 81篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 20篇 |
妇产科学 | 9篇 |
基础医学 | 134篇 |
口腔科学 | 29篇 |
临床医学 | 75篇 |
内科学 | 166篇 |
皮肤病学 | 5篇 |
神经病学 | 144篇 |
特种医学 | 41篇 |
外科学 | 92篇 |
综合类 | 11篇 |
预防医学 | 146篇 |
眼科学 | 64篇 |
药学 | 64篇 |
肿瘤学 | 57篇 |
出版年
2022年 | 9篇 |
2021年 | 15篇 |
2020年 | 11篇 |
2019年 | 10篇 |
2018年 | 20篇 |
2017年 | 6篇 |
2016年 | 14篇 |
2015年 | 14篇 |
2014年 | 29篇 |
2013年 | 53篇 |
2012年 | 47篇 |
2011年 | 54篇 |
2010年 | 32篇 |
2009年 | 28篇 |
2008年 | 64篇 |
2007年 | 45篇 |
2006年 | 37篇 |
2005年 | 40篇 |
2004年 | 39篇 |
2003年 | 35篇 |
2002年 | 34篇 |
2001年 | 20篇 |
2000年 | 19篇 |
1999年 | 18篇 |
1998年 | 6篇 |
1997年 | 7篇 |
1996年 | 15篇 |
1995年 | 13篇 |
1994年 | 12篇 |
1993年 | 8篇 |
1992年 | 15篇 |
1991年 | 25篇 |
1990年 | 18篇 |
1989年 | 18篇 |
1988年 | 21篇 |
1987年 | 29篇 |
1986年 | 16篇 |
1985年 | 15篇 |
1984年 | 16篇 |
1983年 | 15篇 |
1981年 | 9篇 |
1979年 | 9篇 |
1978年 | 12篇 |
1977年 | 9篇 |
1976年 | 10篇 |
1975年 | 6篇 |
1974年 | 6篇 |
1972年 | 11篇 |
1970年 | 6篇 |
1965年 | 5篇 |
排序方式: 共有1061条查询结果,搜索用时 31 毫秒
71.
72.
Melse-Boonstra A Lievers KJ Blom HJ Verhoef P 《The American journal of clinical nutrition》2004,80(3):700-704
BACKGROUND: Before dietary folate is absorbed, polyglutamate folates are deconjugated to monoglutamates by folylpoly-gamma-glutamyl carboxypeptidase in the small intestine. The 1561T allele of the glutamate carboxypeptidase II gene (GCPII), which codes for folylpoly-gamma-glutamyl carboxypeptidase, may impair intestinal absorption of dietary folates. OBJECTIVE: Our aim was to study the bioavailability of polyglutamyl folic acid relative to that of monoglutamyl folic acid across GCPII 1561 genotypes. DESIGN: In a randomized study, 180 healthy adults aged 50-75 y received 323 nmol monoglutamyl folic acid/d (n = 59), 262 nmol heptaglutamyl folic acid/d (n = 61), or placebo (n = 60) for 12 wk. Genotypes were assessed after the intervention. The bioavailability of heptaglutamyl folic acid relative to that of monoglutamyl folic acid was calculated by using the changes in serum folate concentration in the treatment groups, after correction for changes in the placebo group and for the administered dose. RESULTS: No subjects with the TT genotype were encountered. At baseline, serum and erythrocyte folate concentrations were higher (P < 0.05) in subjects with the CT genotype [16.3 nmol/L (geometric x; 95% CI: 13.7, 19.3 nmol/L) and 863 nmol/L (735, 1012 nmol/L), respectively; n = 19] than in subjects with the CC genotype [13.7 (13.1, 14.3) and 685 (652, 721) nmol/L, respectively; n = 161]. Baseline homocysteine concentrations were not significantly different between genotypes. The bioavailability of heptaglutamyl folic acid relative to that of monoglutamyl folic acid was not significantly different between subjects with the CC (64%; 52%, 76%) and CT genotypes (70%; 49%, 91%). CONCLUSIONS: The 1561T allele of the GCPII gene does not impair the bioavailability of polyglutamyl folic acid. However, the allele is associated with higher folate status. This association may be explained by yet unidentified factors controlling the expression of the GCPII gene. 相似文献
73.
Neurologic course, endocrine dysfunction and triplet repeat size in spinal bulbar muscular atrophy 总被引:1,自引:0,他引:1
Sinnreich M Sorenson EJ Klein CJ 《The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques》2004,31(3):378-382
OBJECTIVE: To study the role of diabetes, gynecomastia and CAG triplet repeat size as disease modifying factors of neurologic expression in spinal bulbar muscular atrophy (SBMA, Kennedy's disease). METHODS: Twenty unrelated SBMA patients with confirmatory genetic testing were reviewed. Patterns of neurologic involvement were assessed (e.g. bulbar, asymmetric, proximal, distal, motor and sensory). Slopes of disease progression were calculated from serial quantified neurologic examinations. Patterns of neurologic involvement and course were correlated to the presence of diabetes, gynecomastia and triplet repeat size. RESULTS: Diabetes or glucose impairment occurred in nine and 11 had gynecomastia. Patterns of neurologic involvement and rates of progression did not correlate with these endocrine diseases or triplet repeat sizes. Correlation was seen between number of CAG repeats and age of onset weakness (r = -0.53, r2 = 29%, p = 0.01). CONCLUSIONS: The specific neurotoxic effect of expanded CAGs appears limited to age of onset weakness in SBMA. Although significant, only 29% of the variability in onset age could be accounted for by polyglutamine size suggesting the importance of other unidentified factors. In this series diabetes or glucose impairment was more common than previously reported and, like gynecomastia, did not correlate with size of triplet repeats, severity or patterns of neurologic involvement. Modifying factors other than diabetes, gynecomastia or triplet repeat size are suggested in disease expression. 相似文献
74.
Spalloni A Pascucci T Albo F Ferrari F Puglisi-Allegra S Zona C Bernardi G Longone P 《Neuroreport》2004,15(16):2477-2480
The neurotoxicity of the AMPA/kainate receptor agonist kainate was investigated in motor and cortical neurones from mice over-expressing the wild-type and G93A mutant form of Cu/Zn superoxide dismutase (SOD1) human gene, a mouse model of familial amyotrophic lateral sclerosis. G93A mutant motor neurones were more vulnerable and wild-type SOD1 motor neurones were more resistant to kainate toxicity than were controls. Voltage-gated Na channels blockage prevented G93A mutant SOD1 motor neurone death. Cortical cultures exhibited fewer differences in their vulnerability to kainate toxicity. These results demonstrate that SOD1 over-expression selectively affects the sensitivity to kainate excitotoxicity of motor neurones but not neocortical neurones, and that wild-type SOD1 expression increases the resistance to excitotoxicity of motor neurones. 相似文献
75.
Windebank AJ Sorenson EJ Civil R O'Brien PC 《Journal of the peripheral nervous system : JPNS》2004,9(3):183-189
Idiopathic, painful, small fiber predominant peripheral neuropathy is resistant to symptomatic treatment. Previous treatments have not been directed toward repairing the underlying deficit. Growth factors hold promise as agents to encourage axonal regrowth. In vitro, insulin-like growth factor-I (IGF-I) has been shown to prevent neuronal apoptosis, to increase axonal growth, and to support myelination. Using a double-blind, placebo-controlled design, 40 patients were randomized to treatment with recombinant human IGF-I (0.05 mg/kg twice daily by subcutaneous injection) or placebo for 6 months. There were no significant adverse events and minor adverse events occurred equally in both groups. The primary outcome measure was change in score on an analog pain scale. Secondary endpoints included quantitative sensory testing, quantitative autonomic testing, neuropathy impairment score, nerve conduction studies, and neuropathy symptom and change score. There was no significant difference in the primary endpoint between the two groups. Analysis of secondary endpoints and a global impression of improvement by patients and physicians did not show consistent differences between the groups. IGF-I was safe, but did not improve symptoms in this 6-month trial. 相似文献
76.
77.
Schuring-Blom GH Boer K Knegt AC Verjaal M Leschot NJ 《European journal of obstetrics, gynecology, and reproductive biology》2002,101(2):161-168
OBJECTIVE: The finding of full or mosaic trisomy 13 or 18 in first trimester chorionic villus sampling (CVS) may be a false-positive result. This report provides incidence and outcome information that may be helpful in counselling individual patients and in choosing adequate follow-up. STUDY DESIGN: From a series of 6820 CVS cases, we retrospectively collected data on all patients (n=51) with full (n=30) or mosaic (n=5) trisomy 18, and full (n=13) or mosaic (n=3) trisomy 13 in cytotrophoblast cells. RESULTS: Five false-positives were seen in patients with full trisomy 18 and three in the mosaic cases. One false-positive result was observed in full trisomy 13 and two false-positives in cases of mosaicism. No false-negative results were reported. CONCLUSION: The diagnosis of trisomy 13 or 18 in cytotrophoblasts should be confirmed in other tissues, unless fetal abnormalities are seen at ultrasound. In case of mosaicism, follow-up amniocentesis is advised. 相似文献
78.
79.
Sanderson P McNulty H Mastroiacovo P McDowell IF Melse-Boonstra A Finglas PM Gregory JF;UK Food Standards Agency 《The British journal of nutrition》2003,90(2):473-479
The UK Food Standards Agency convened a group of expert scientists to review current research investigating folate bioavailability. The workshop aimed to overview current research and establish priorities for future research. Discrepancies were observed in the evidence base for folate bioavailability, especially with regard to the relative bioavailability of natural folates compared with folic acid. A substantial body of evidence shows folic acid to have superior bioavailability relative to food folates; however, the exact relative bioavailability still needs to be determined, and in particular with regard to mixed diets. The bioavailability of folate in a mixed diet is probably not a weighted average of that in the various foods consumed; thus the workshop considered that assessment of folate bioavailability of whole diets should be a high priority for future research. 相似文献
80.
Probing biopolymers with the atomic force microscope: a review 总被引:1,自引:0,他引:1
Hansma HG Pietrasanta LI Auerbach ID Sorenson C Golan R Holden PA 《Journal of biomaterials science. Polymer edition》2000,11(7):675-683
This short review presents an overview of atomic force microscopy (AFM) of biopolymers and specific examples of some of the biopolymers that have been analyzed by AFM. These specific examples include extracellular polymeric substances on the surfaces of bacterial biofilms, condensed DNA, DNA constructs, and DNA-protein interactions. In addition, two examples are presented for AFM analyses of proteins: laminin flexing its arms in solution and neurofilaments entropically brushing away the space around themselves. 相似文献